2026 NPPES data Pediatric Allergy/Immunology Physician NPI 1235391640 M.D.
Verify on CMS →

MUDITA GOGNA, M.D.

Pediatric Allergy/Immunology Physician in ROSEVILLE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
237
Medicare Part D claims · 75 beneficiaries · Pediatric Allergy/Immunology Physician avg: 345
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
68.0479/100
▼ 15 pts below national avg 83.1 · [object Object]
Industry payments
$563.07
16 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MUDITA GOGNA, M.D. is a Pediatric Allergy/Immunology Physician ([object Object]) practicing in ROSEVILLE, California with a Medicare Part D prescribing footprint of 237 claims across 75 beneficiaries — 39% brand-name prescribing . Their CMS MIPS Final Score of 68.0479/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $563.07 across 16 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MUDITA GOGNA, M.D. reported a CMS MIPS final score of 68.0479 out of 100, below the 83.1 national average, and filed 237 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MUDITA GOGNA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MUDITA GOGNA, M.D. at a glance

Below national average

NPI registry status

Active

Issued 06/26/2008

NPI 1235391640

Primary specialty

Pediatric Allergy/Immunology Physician

Rare

419 US NPIs in this specialty

Medicare Part D claims

237 31% vs specialty avg

2023 prescription claims

Specialty avg: 345

MIPS final score

68.0479/100 15.052099999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Pediatric Allergy/Immunology Physician compares to other specialties among California providers

California providers

Pediatric Allergy/Immunology Physician share within California

1. Pediatric Allergy/Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Allergy/Immunology Physician share within California

Medicare quality performance — MIPS

MUDITA GOGNA, M.D.'s 2023 MIPS final score plotted against the Pediatric Allergy/Immunology Physician national average

Below national average
MIPS Final Score
68.0479/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pediatric Allergy/Immunology Physician) — 68.0479/100 vs national avg 83.1

0%100%National avg83%68%
MIPS final score (Pediatric Allergy/Immunology Physician) — 68.0479/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MUDITA GOGNA, M.D. is a Pediatric Allergy/Immunology Physician provider practicing in ROSEVILLE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1235391640. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MUDITA GOGNA, M.D. appears in the CMS NPPES registry as a Pediatric Allergy/Immunology Physician provider holding M.D. credentials at 1528 EUREKA RD STE 102, ROSEVILLE, CA, 95661, with a listed phone of (916) 736-6644. NPI 1235391640 was issued on 06/26/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOGNA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 237 prescription claims written by this provider, covering 75 Medicare beneficiaries and totaling roughly $120K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 68.0479/100 for the 2023 performance year (Quality 56.1049, Cost 37.666), compared with the national average of 83.1.

Pediatric Allergy/Immunology Physician is a narrow specialty nationwide, with 419 enrolled providers across 43 states and an average of 345 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1528 EUREKA RD STE 102
ROSEVILLE, CA 95661

Provider Details

NPI 1235391640
Specialty Pediatric Allergy/Immunology Physician
Credentials M.D.
Gender Female
NPI Issued 06/26/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

68.0479
Final Score
Avg: 83.1
56.1049
Quality
37.666
Cost
94
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MUDITA GOGNA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SACRAMENTO EAR NOSE AND THROAT SURGICAL AND MEDICAL GROUP INC
ROSEVILLE, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MUDITA GOGNA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$563

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MUDITA GOGNA, M.D.. To verify MUDITA GOGNA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MUDITA GOGNA, M.D. — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 237 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

237
Total Claims
$120K
Total Drug Cost
75
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
336
Total Day Supply
9,256
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$113K
Generic Drug Cost
$6K
Antibiotic Claims
15

Patient Demographics

Average Patient Age
67.5 years
Avg HCC Risk Score
1.05
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Montelukast Sodium
28
Ipratropium Bromide
27
Spiriva Respimat
Tiotropium Bromide
20
Azelastine Hcl
19
Breo Ellipta
Fluticasone/Vilanterol
16
Symbicort
Budesonide/Formoterol Fumarate
13
Dupixent Pen
Dupilumab
12
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
12
Triamcinolone Acetonide
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Allergy/Immunology Physician Overview

How MUDITA GOGNA, M.D. fits within the Pediatric Allergy/Immunology Physician landscape nationally.

419
Pediatric Allergy/Immunology Physician Providers in US
43
States with Pediatric Allergy/Immunology Physician
345
Avg Claims per Provider

MUDITA GOGNA, M.D.'s 237 claims are below the specialty average of 345.

Nearby Pediatric Allergy/Immunology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GOGNA.

Compare Pediatric Allergy/Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MUDITA GOGNA, M.D.'s specialty?
MUDITA GOGNA, M.D. specializes in Pediatric Allergy/Immunology Physician and practices in ROSEVILLE, California. Credentials: M.D..
How much does MUDITA GOGNA, M.D. prescribe under Medicare Part D?
In 2023, MUDITA GOGNA, M.D. wrote 237 Medicare Part D claims totaling $120K in drug costs for 75 beneficiaries.
What is MUDITA GOGNA, M.D.'s Medicare quality score?
MUDITA GOGNA, M.D. has a CMS MIPS Final Score of 68.0479/100 (Quality: 56.1049, Cost: 37.666). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MUDITA GOGNA, M.D. located?
MUDITA GOGNA, M.D. is located at 1528 EUREKA RD STE 102, ROSEVILLE, CA, 95661. Phone: (916) 736-6644.
What is MUDITA GOGNA, M.D.'s NPI number?
MUDITA GOGNA, M.D.'s National Provider Identifier (NPI) is 1235391640, issued on 06/26/2008.
Does MUDITA GOGNA, M.D. prescribe more brand-name or generic drugs?
MUDITA GOGNA, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $113K in brand drug costs.
How many Pediatric Allergy/Immunology Physician providers are there in the US?
There are 419 Pediatric Allergy/Immunology Physician providers across 43 states in the US. The average Pediatric Allergy/Immunology Physician provider writes 345 Medicare Part D claims per year.
What drugs does MUDITA GOGNA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MUDITA GOGNA, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Ipratropium Bromide, Spiriva Respimat. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MUDITA GOGNA, M.D. accept Medicare?
MUDITA GOGNA, M.D. appears in CMS Medicare data with 237 Part D claims and 75 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MUDITA GOGNA, M.D.'s credentials?
MUDITA GOGNA, M.D.'s NPI is 1235391640 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology